These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 23001516

  • 1. Do predictors of incomplete Kawasaki disease exist for infants?
    No SJ, Kim DO, Choi KM, Eun LY.
    Pediatr Cardiol; 2013 Feb; 34(2):286-90. PubMed ID: 23001516
    [Abstract] [Full Text] [Related]

  • 2. Risk of coronary artery lesions in young infants with Kawasaki disease: need for a new diagnostic method.
    Satoh K, Wakejima Y, Gau M, Kiguchi T, Matsuda N, Takasawa R, Takasawa K, Nishioka M, Shimohira M.
    Int J Rheum Dis; 2018 Mar; 21(3):746-754. PubMed ID: 29105337
    [Abstract] [Full Text] [Related]

  • 3. [Change in plasma N-terminal pro-brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice].
    Zhang QY, Du JB, Chen YH, Li WZ.
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):886-90. PubMed ID: 17254452
    [Abstract] [Full Text] [Related]

  • 4. Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease.
    Reddy M, Singh S, Rawat A, Sharma A, Suri D, Rohit MK.
    Rheumatol Int; 2016 Apr; 36(4):551-9. PubMed ID: 26849890
    [Abstract] [Full Text] [Related]

  • 5. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
    Kitoh T, Ohara T, Muto T, Okumura A, Baba R, Koizumi Y, Yamagishi Y, Mikamo H, Daigo K, Hamakubo T.
    Front Immunol; 2021 Apr; 12():624802. PubMed ID: 33912155
    [Abstract] [Full Text] [Related]

  • 6. Echocardiographic Parameters During and Beyond Onset of Kawasaki Disease Correlate with Onset Serum N-Terminal pro-Brain Natriuretic Peptide (NT-proBNP).
    Desjardins L, Dionne A, Meloche-Dumas L, Fournier A, Dahdah N.
    Pediatr Cardiol; 2020 Jun; 41(5):947-954. PubMed ID: 32172336
    [Abstract] [Full Text] [Related]

  • 7. Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age.
    Song D, Yeo Y, Ha K, Jang G, Lee J, Lee K, Son C, Lee J.
    Eur J Pediatr; 2009 Nov; 168(11):1315-21. PubMed ID: 19159953
    [Abstract] [Full Text] [Related]

  • 8. Brain natriuretic peptide as a hormonal marker of ventricular diastolic dysfunction in children with Kawasaki disease.
    Kurotobi S, Kawakami N, Shimizu K, Aoki H, Nasuno S, Takahashi K, Kogaki S, Ozono K.
    Pediatr Cardiol; 2005 Nov; 26(4):425-30. PubMed ID: 15633045
    [Abstract] [Full Text] [Related]

  • 9. Myocardial Assessment in School-Aged Children with Past Kawasaki Disease.
    Lee H, Shin J, Eun L.
    J Korean Med Sci; 2017 Nov; 32(11):1835-1839. PubMed ID: 28960037
    [Abstract] [Full Text] [Related]

  • 10. Abnormal tissue doppler images are associated with elevated plasma brain natriuretic peptide and increased oxidative stress in acute Kawasaki disease.
    Takeuchi D, Saji T, Takatsuki S, Fujiwara M.
    Circ J; 2007 Mar; 71(3):357-62. PubMed ID: 17322635
    [Abstract] [Full Text] [Related]

  • 11. Adjuvant laboratory marker of Kawasaki disease; NT-pro-BNP or hs-CRP?
    Cho SY, Kim Y, Cha SH, Suh JT, Han MY, Lee HJ.
    Ann Clin Lab Sci; 2011 Mar; 41(4):360-3. PubMed ID: 22166506
    [Abstract] [Full Text] [Related]

  • 12. [Levels of serum brain natriuretic peptide and the correlation to heart function in children with Kawasaki disease].
    Sun YP, Wang WD, Zheng XC, Wang JJ, Ma SC, Xu YJ.
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Mar; 12(3):169-71. PubMed ID: 20350422
    [Abstract] [Full Text] [Related]

  • 13. N-terminal pro-B-type natriuretic peptide diagnostic algorithm versus American Heart Association algorithm for Kawasaki disease.
    Dionne A, Meloche-Dumas L, Desjardins L, Turgeon J, Saint-Cyr C, Autmizguine J, Spigelblatt L, Fournier A, Dahdah N.
    Pediatr Int; 2017 Mar; 59(3):265-270. PubMed ID: 27589358
    [Abstract] [Full Text] [Related]

  • 14. Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease.
    Dahdah N, Siles A, Fournier A, Cousineau J, Delvin E, Saint-Cyr C, Spiegelblatt L, Bonny Y, Vartian M, Montigny M.
    Pediatr Cardiol; 2009 Aug; 30(6):810-7. PubMed ID: 19365652
    [Abstract] [Full Text] [Related]

  • 15. Correlation between NT-pro BNP levels and early mitral annulus velocity (E') in patients with non-ST-segment elevation acute coronary syndrome.
    Barbosa MM, Nunes Mdo C, Castro LR, Nominato LF, Alencar MC, Ribeiro AL.
    Echocardiography; 2008 Apr; 25(4):353-9. PubMed ID: 18177379
    [Abstract] [Full Text] [Related]

  • 16. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
    Ye Q, Shao WX, Shang SQ, Zhang T, Hu J, Zhang CC.
    Arthritis Rheumatol; 2015 Jul; 67(7):1943-50. PubMed ID: 25778686
    [Abstract] [Full Text] [Related]

  • 17. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
    Huiling L, Yaping L, Xiufen H.
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507
    [Abstract] [Full Text] [Related]

  • 18. Kawasaki disease in infants less than one year of age: an Italian cohort from a single center.
    Mastrangelo G, Cimaz R, Calabri GB, Simonini G, Lasagni D, Resti M, Trapani S.
    BMC Pediatr; 2019 Sep 07; 19(1):321. PubMed ID: 31493782
    [Abstract] [Full Text] [Related]

  • 19. Echo-Doppler assessment of arterial stiffness in pediatric patients with Kawasaki disease.
    AlHuzaimi A, Al Mashham Y, Potts JE, De Souza AM, Sandor GG.
    J Am Soc Echocardiogr; 2013 Sep 07; 26(9):1084-9. PubMed ID: 23800509
    [Abstract] [Full Text] [Related]

  • 20. N-terminal probrain natriuretic peptide as biomarker for diagnosis of Kawasaki disease.
    Rodriguez-Gonzalez M, Perez-Reviriego AA, Castellano-Martinez A, Cascales-Poyatos HM.
    Biomark Med; 2019 Mar 07; 13(4):307-323. PubMed ID: 30900472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.